Adstiladrin (nadofaragene firadenovec)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adstiladrin (nadofaragene firadenovec), covering 2026-04-20 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer [Phase 3]